The US sports medicine device market had been significantly impacted by treatment deferrals and the elective nature of sports medicine procedures following the COVID-19 pandemic; however, by 2022,…
Driven by product innovation, rising kidney stone prevalence, and an aging population, the market for US urological devices will grow at a modest rate through 2032 despite the significant impact of…
The impact of the COVID-19 pandemic on the US trauma device market was relatively lesser due to the urgent nature of the procedures involved. Moving forward, the market’s growth will remain…
The US EP mapping and ablation device market will experience moderate growth through 2032, with trends varying by device segment. The COVID-19 pandemic had a significant impact on some EP ablation…
The US neurovascular device market will see moderate growth through 2032 driven by the growing adoption of thrombectomy for managing acute ischemic stroke, the launch of new embolization and…
The US market for interventional oncology devices will grow through 2032. This will be driven largely by the increasing shift toward higher-priced technologies, such as radioembolization, and…
The US open surgery instrument market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent…
The US dialysis access treatment device market will be driven by the increasing patient population in need of dialysis care, the launch of new devices featuring innovative technologies, and…
The US laparoscopic device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent modest…
The US TEO device market will expand at a moderate rate over the forecast period after recovering from the impact of COVID-19. The market factors contributing to this growth will include the…
The US aortic repair device market will be bolstered by the impact of positive clinical trial results and new stent graft launches, which will drive the increased adoption of endovascular and…
Following the recovery from the impact of the COVID-19 pandemic, the US diagnostic imaging system market will see marginal growth through 2032. Manufacturers in this space are actively introducing…
Although the US enterprise solution market was negatively impacted during the height of the COVID-19 global pandemic, the market continues to recover and will ultimately see robust growth through…
The breast implant and reconstructive device market in the US is expected to experience modest growth over the forecast period, driven by factors such as a high aesthetic consciousness in the…
Following strong recovery from COVID-19–related procedure delays in 2021, the large-joint reconstructive implant market has returned to a more moderate growth rate. Long-term growth of the market…